{"id":1563,"date":"2023-08-25T10:27:00","date_gmt":"2023-08-25T02:27:00","guid":{"rendered":"https:\/\/vcro.online\/?p=1563"},"modified":"2024-07-15T15:52:07","modified_gmt":"2024-07-15T07:52:07","slug":"great-news-tfda-has-approved-phase-iii-clinical-trials-for-the-use-of-bnct-in-the-treatment-of-rgbm-with-small-molecule-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=1563","title":{"rendered":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals."},"content":{"rendered":"\n<p>In August 2023, the professional team from VCRO assisted the client in submitting the clinical trial application of their small molecule for the use of boron neutron capture therapy (BNCT) in the treatment of recurrent glioblastoma multiforme (rGBM). The team successfully obtained TFDA approval to proceed with Phase III clinical trials. We successfully supported our clients in smoothly advancing to the Phase III clinical trial stage. VCRO is here to accompany you through every stage of the clinical trial process.<\/p>\n\n\n<figure class=\"wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"\" style=\"object-fit:cover;\" srcset=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg 1024w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e-300x300.jpg 300w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e-150x150.jpg 150w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e-768x768.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>","protected":false},"excerpt":{"rendered":"<p>In August 2023, the professional team from VCRO assisted the client in submitting the clinical trial application of their small molecule for the use of boron neutron capture therapy (BNCT) in the treatment of recurrent glioblastoma multiforme (rGBM). The team successfully obtained TFDA approval to proceed with Phase III clinical trials. We successfully supported our [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1721,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1563","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vcro-express"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. - VCRO<\/title>\r\n<meta name=\"description\" content=\"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=1563\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=1563\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2023-08-25T02:27:00+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-15T07:52:07+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals.\",\"datePublished\":\"2023-08-25T02:27:00+00:00\",\"dateModified\":\"2024-07-15T07:52:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563\"},\"wordCount\":102,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg\",\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=1563\",\"name\":\"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg\",\"datePublished\":\"2023-08-25T02:27:00+00:00\",\"dateModified\":\"2024-07-15T07:52:07+00:00\",\"description\":\"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=1563\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563#primaryimage\",\"url\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg\",\"contentUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1563#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. - VCRO","description":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=1563","og_locale":"en_US","og_type":"article","og_title":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. - VCRO","og_description":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=1563","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2023-08-25T02:27:00+00:00","article_modified_time":"2024-07-15T07:52:07+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg","type":"image\/jpeg"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=1563#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=1563"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals.","datePublished":"2023-08-25T02:27:00+00:00","dateModified":"2024-07-15T07:52:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1563"},"wordCount":102,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=1563#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg","articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=1563","url":"https:\/\/www.vcro.com.tw\/?p=1563","name":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1563#primaryimage"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=1563#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg","datePublished":"2023-08-25T02:27:00+00:00","dateModified":"2024-07-15T07:52:07+00:00","description":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals. VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=1563#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=1563"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/?p=1563#primaryimage","url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg","contentUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2023\/08\/eba318dc-d349-4d29-beaf-9dba4aa9ce8e.jpg","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=1563#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Great news! TFDA has approved Phase III clinical trials for the use of BNCT in the treatment of rGBM with small molecule pharmaceuticals."}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1563"}],"version-history":[{"count":3,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1563\/revisions"}],"predecessor-version":[{"id":1722,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1563\/revisions\/1722"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/media\/1721"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}